Grammy-winning R&B singer D’Angelo passed away on October 14 at 51 years old after a private battle with pancreatic malignancy.
“The brilliant light of our household has faded away for us in this life,” his relatives confirmed. “After a lengthy and brave struggle with cancer, we are deeply saddened to announce that D’Angelo, known to his fans around the world as D’Angelo, has been called home.”
D’Angelo made a lasting impact on music with his pioneering modern soul style and partnerships with renowned musicians.
He launched his debut album, “Brown Sugar,” in the mid-nineties to instant praise. The record reached No. 4 on the R&B charts, earned platinum status soon after, and received several award nominations.
However, it was his sophomore release, “Voodoo,” in the year 2000 that boosted his music career into the stratosphere. The album debuted at the top spot on both Billboard’s Top R&B Albums chart and the Billboard 200. He received two Grammys: Top R&B Record and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”
The music video for “Untitled (How Does It Feel)” cemented D’Angelo’s reputation as a icon, albeit a hesitant one, in the cultural zeitgeist. The personal depiction showed the artist, famously stripped down to his waist, performing straight into the lens.
D’Angelo stepped back from the public eye after putting out Voodoo and publicly struggled with drugs and alcohol. In 2005, he was part of a severe car crash that left him in grave health.
Over ten years later, his last record, “Black Messiah” (2014), confirmed his lasting popularity with another top chart entry on the R&B chart and a award for Best R&B Album.
Once more, in his own enigmatic fashion, D’Angelo made only a few public outings in the following years.
The singer was announced as a headliner for the 2025 music event, but his performance was canceled, citing an “unexpected health issue.”
Even though information is limited about D’Angelo’s well-being in the weeks leading up to his death, he had apparently been hospitalized for an extended period and in hospice for two weeks.
D’Angelo’s passing is a stark reminder of the devastating effects of pancreatic malignancy, one of the deadliest and hardest to prevent types of the disease, on a brilliant talent whose existence was ended too soon.
“We are grieved that he can only leave cherished moments with his family, but we are forever thankful for the legacy of deeply emotional songs he leaves behind,” his kin expressed.
Pancreatic malignancy impacts the digestive organ, a small organ that produces the hormone insulin and plays an essential role in breaking down food, among additional roles. The size and location of the organ in the body make it more challenging to detect cancer.
Although this cancer accounts for only about 3% of cancer diagnoses each year in the U.S., it is causes 7% of cancer deaths.
Almost seventy thousand individuals will be diagnosed with pancreatic cancer and about 52,000 will succumb to the disease in 2025.
“This malignancy is one of the most lethal diseases, with an aggressive tumor and poor prognosis. We have few and poor treatment options, and a narrow opportunity to make a significant difference on the well-being of patients,” noted a cancer specialist.
Since this disease seldom produces early symptoms, it’s frequently diagnosed only once the disease is late-stage. Although a patient has indicators they are often vague and may be confused with a several everyday ailments.
“Currently, there is no effective method to identify this malignancy in the early stages, except for listening to your body and consulting your physician if there are unfamiliar symptoms,” said a health expert.
Frequent indicators of pancreatic cancer encompass:
At 51 years old, D’Angelo’s death is an outlier, as pancreatic cancer is typically found in adults in the sixty-five to seventy-five range. However, numerous malignancies, including pancreatic cancer, have become increasingly prevalent in younger people.
“This disease identified prior to fifty is deemed rare, yet alarmingly, doctors are noticing a growing number of younger patients affected by this disease,” commented a specialist.
Without reliable screening tools for pancreatic cancer, experts emphasized the significance of understanding your relatives’ cancer history. Some contributing elements, such as smoking and excess weight also have an influence in the development of pancreatic cancer.
African Americans have the highest incidence of pancreatic cancer in the U.S. and are most likely to be found to have inoperable cancer.
“The first step toward reducing one’s risk of pancreatic cancer is assessing personal risk factors. Individuals should examine their genetic background, hereditary factors, and medical conditions, such as blood sugar disease, long-term pancreas inflammation, or overweight that may increase their susceptibility,” advised a medical professional.
Hereditary risk factors are linked to as much as ten percent of all this malignancy cases. If a relative in your family has had this disease, you may want to consider genetic testing.
“For people with a family history of this condition or those having high risk genetic mutations, checking may involve sophisticated scans such as MRI scans or internal ultrasound to detect initial alterations in the organ,” he clarified.
For those wishing to lower their chance, lifestyle changes may make a difference. The best step you can take to reduce your susceptibility of this disease is to quit smoking, and if you don’t smoke, avoid exposure altogether.
Heavy drinking is associated with pancreatitis, a contributing element for this malignancy, so limiting or avoiding drinks may assist reduce your risk.
Controlling your weight or shedding pounds may also help reduce your risk. People with obesity are 20% more likely to get pancreatic cancer. Pancreatic cancer also is more frequent in people with diabetes, and weight loss can also reduce the chance of adult-onset diabetes.
Despite pancreatic cancer’s grim outlook, there is reason for optimism.
“We are doing better with therapies and more recent mixed drug treatments. There are developing precision medicines that already are making an impact,” said a specialist.
For many people, however, education about this uncommon but {dev
Tech journalist and innovation analyst with a passion for exploring emerging technologies and their impact on daily life.